Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
出版年份 2015 全文链接
标题
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
作者
关键词
Targeted therapy, Tumor, Cell death, Cell growth, Neutralizing antibody, Heparan sulfate
出版物
Molecular Cancer
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-07-22
DOI
10.1186/s12943-015-0391-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
- (2014) N Cihoric et al. BRITISH JOURNAL OF CANCER
- Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
- (2013) R. Dienstmann et al. ANNALS OF ONCOLOGY
- Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations
- (2013) Han Kiat Ho et al. DRUG DISCOVERY TODAY
- FGFR signalling in women's cancers
- (2013) Abbie E. Fearon et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- FGFR1 Signaling Stimulates Proliferation of Human Mesenchymal Stem Cells by Inhibiting the Cyclin-Dependent Kinase Inhibitors p21Waf1and p27Kip1
- (2013) Christian Dombrowski et al. STEM CELLS
- FGF Receptor Inhibitors: Role in Cancer Therapy
- (2012) Gennaro Daniele et al. Current Oncology Reports
- Targeting mutant fibroblast growth factor receptors in cancer
- (2011) Heidi Greulich et al. TRENDS IN MOLECULAR MEDICINE
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
- (2010) N. Turner et al. CANCER RESEARCH
- Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts
- (2010) W.-m. Zhao et al. CLINICAL CANCER RESEARCH
- Synergism between Wnt3a and Heparin Enhances Osteogenesis via a Phosphoinositide 3-Kinase/Akt/RUNX2 Pathway
- (2010) Ling Ling et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nrf2: friend or foe for chemoprevention?
- (2009) T. W. Kensler et al. CARCINOGENESIS
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1)
- (2009) Barry P. Pereira et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
- (2009) Jing Qing et al. JOURNAL OF CLINICAL INVESTIGATION
- De-regulated FGF receptors as therapeutic targets in cancer
- (2009) Victoria Knights et al. PHARMACOLOGY & THERAPEUTICS
- Oxidative Stress and Oxidative Damage in Carcinogenesis
- (2009) James E. Klaunig et al. TOXICOLOGIC PATHOLOGY
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started